Knee pain affects millions, often limiting movement and impacting daily life. Many people want to avoid surgery, looking for effective treatments that cause less disruption. Arthrosamid injections have become a popular non-surgical option, especially in private healthcare across the UK.

This article explores whether Arthrosamid injections are worth considering. We’ll look at how well they work, what patients say, how much they cost, and who might benefit most. By drawing on expert insights from leading centres like MSK Doctors and orthopaedic specialist Professor Paul Lee, this guide aims to help you make an informed choice.

What Do Studies and Patient Reviews Reveal About Arthrosamid?

Several studies have tested Arthrosamid injections for knee pain caused by osteoarthritis, with many patients reporting significant relief and better joint function. One recent analysis found that Arthrosamid “offers comparable short-term efficacy and modest advantage at 6 months,” although its long-term benefits seem less clear-cut.

Encouragingly, a three-year follow-up study showed that “single injections of 6 ml intra-articular iPAAG are well tolerated and continue to provide clinically relevant and statistically significant effectiveness.” Another study comparing Arthrosamid with hyaluronic acid found it “approached superiority at 52 weeks” and was especially effective for people under 70, those with a normal body mass index, or moderate knee osteoarthritis.

Still, it’s important to remember that results differ among individuals. Some experience lasting relief, while others may notice only short-term or moderate improvements. That’s why clinics such as MSK Doctors focus on thorough assessments and tailor treatments to each patient’s needs, helping set realistic expectations.

Understanding Arthrosamid Costs in the UK: What Patients Can Expect

In private UK clinics, Arthrosamid injections usually cost between £1,500 and £3,000 per treatment session. This typically covers consultations, scans, the injection itself, and follow-up care, although prices can vary.

Compared with alternatives like corticosteroid or hyaluronic acid injections, Arthrosamid is generally more expensive but less costly than knee surgery. Research shows that Arthrosamid “was better than steroid at 6 months but not hyaluronic acid, with no significant differences at 12 months.” Given its potential for longer-lasting pain relief, this upfront cost might save money over time by reducing the need for repeat treatments or surgery.

It’s wise to discuss all costs clearly with your clinic and check your insurance options to plan your finances confidently.

Who Benefits Most – And Who Might Not

Arthrosamid injections tend to work best for people with mild to moderate osteoarthritis who haven’t found relief through other treatments. Ideal candidates are often active, middle-aged or older adults without severe joint damage or complex health issues.

Studies back this up, showing Arthrosamid had the highest rates of patient satisfaction and meaningful clinical improvement at 3 and 6 months. Long-term results also demonstrated “clinically relevant and statistically significant decreases” in pain and stiffness up to three years after treatment.

Subgroup research further reveals that people under 70 years old, those with a normal BMI, and those with moderate (KL grade 2–3) osteoarthritis saw the most benefit. Patients with more advanced knee damage or significant deformity may be better suited to other treatments, including surgery.

At MSK Doctors, led by Professor Paul Lee, patients receive personalised assessments to ensure they get the right treatment for their individual condition.

Talking With Your Specialist: Questions to Ask and Setting Expectations

Preparing thoughtful questions for your consultation can make a big difference. Ask about the expected benefits and risks of Arthrosamid injections, how long relief might last, alternative treatments available, and what aftercare to expect.

Shared decision-making is key. Research notes that “further prospective studies are needed to define its optimal use,” so it’s important to discuss how likely the treatment is to help your specific case. Open conversations will help you understand realistic outcomes and feel confident about your choice.

Specialists like Professor Paul Lee and the MSK Doctors team provide knowledgeable, compassionate support throughout this process to ensure you feel informed and comfortable.

Conclusion

Arthrosamid injections offer a promising non-surgical option to ease knee pain, backed by evidence showing pain reduction and improved function that may last several years for many patients. They seem particularly effective for younger, healthier individuals with moderate osteoarthritis.

Ultimately, the decision to proceed should be based on your unique situation, financial considerations, and professional advice. By working closely with experienced orthopaedic specialists such as those at MSK Doctors, you can make an educated, confident choice for managing your knee pain.

References

• Aykaç, B., Dinç, M., Nar, Ö. O., Karasu, R., & Bayrak, H. Ç. (2025). Comparative efficacy of polyacrylamide hydrogel versus hyaluronic acid and corticosteroids in knee osteoarthritis: A retrospective cohort study. Medicine. Advance online publication. https://doi.org/10.1097/MD.0000000000044655
• Bliddal, H., Beier, J., Hartkopp, A., Conaghan, P., & Henriksen, M. (2023). Polyacrylamide hydrogel for the treatment of knee osteoarthritis: 3 year follow up results of a prospective clinical study. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2023-eular.6038
• Bliddal, H., Beier, J., Hartkopp, A., Conaghan, P., & Henriksen, M. (2023). Polyacrylamide hydrogel versus hyaluronic acid in knee osteoarthritis: A subgroup analysis of a randomized study. Bone & Joint Research, 13(Suppl 1). https://doi.org/10.1302/1358-992x.2023.13.081